Provide process research and development for production purposes: process route development, screening, and optimization; Process parameters and safety assessment;
Provide high-quality and cost-effective customized services: design, research and development, optimization, and production of complex pharmaceutical intermediates, with product scales ranging from grams to tonnages, ensuring fast delivery.
A professional technology transfer team, through pilot process validation and evaluation, provides support for scale production.
Equipped with 2 synthetic workshops; 95% of the reactors meet multifunctional requirements, featuring high efficiency, stability, and controllability, enabling the scaled-up production of small-molecule pharmaceutical intermediates for customer service.
The separation and purification platform is equipped with multiple sets of analytical instruments, including imported high-performance liquid chromatography, gas chromatography, and mass spectrometry systems from Waters and Agilent. It possesses the capability to handle medium/high-pressure preparation and post-processing at industrial production scales, as well as ion exchange systems, molecular distillation, membrane filtration, and electrodialysis systems. Meanwhile, while continuously enhancing its core competitive capabilities, it also meets customers' personalized commercial needs.
Cosychem analytical quality control platform focuses on the quality research services of chemical small molecule drug raw materials, molecular diagnostic raw materials, small nucleic acid drug raw materials, and delivery system raw materials. It is equipped with various types of chemical and biological analysis and detection equipment, such as HPLC, GC, LCMS, NMR, UPLC-TOF, PCR amplification instrument, fluorescent quantitative PCR instrument, electrophoresis instrument, gel imaging analysis system, etc. It has CNAS, ISO and other laboratory qualifications and GMP quality management guarantee system. It cooperates with domestic first-class universities and scientific research institutes in an all-round way to jointly build joint laboratories, which can support the research and development, production, registration and third-party testing of chemical and biological projects at the same time, and can meet the diversified testing needs of different customers.
The structural identification platform has multiple experienced structural analysis experts who can use techniques such as nuclear magnetic resonance, high-resolution mass spectrometry, and spectroscopy to comprehensively characterize the structures of chemically synthesized small molecules, natural products, peptides, oligonucleotides, and more..
One-stop analysis and testing service platform Precise Testing, Empowered R&D
CNAS Identification: Some of the raw material testing projects have been recognized by the China National Accreditation Service for Conformity Assessment (CNAS) and have the qualification to issue internationally recognized testing reports.
Standard compliance: The testing process strictly follows the guidelines of the Chinese Pharmacopoeia (ChP), United States Pharmacopeia (USP), European Pharmacopoeia (EP), and ICH.
Data integrity: Strictly implement data integrity management to ensure traceability between the graph and the original records.
